Insulet Corporation (PODD): This Diabetes Stock Is A Good Addition To Your Portfolio Now

By Yahoo! Finance | Aug 16, 2024 at 09:04 PM EST

Insulet Corporation (NASDAQ:PODD) is a key player in the diabetes stock market. Despite inventory concerns, its Omnipod devices show strong demand, leading to increased revenue projections. Analysts suggest a positive outlook with a 19.47% potential rise in stock price.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.